ArticleCureus2025
Artificial Intelligence in Oculoplastics: A Survey-Based Study on Provider Perspective.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose This survey aims to explore the attitudes of ophthalmologist oculoplastic surgeons in the United Kingdom (UK) towards specific advances in artificial intelligence (AI). Methods A web-based anonymised survey was distributed to oculoplastic surgeons in the UK between October 2023 and March 2024. The survey evaluated attitudes towards specific AI advances using a five-point scale. Questions were designed to ascertain understanding, application, as well as attitudes towards anticipated future developments, barriers and challenges of AI within the current oculoplastic clinical landscape. Results In total, 77 survey responses were analysed from oculoplastic surgeons practising around the UK. The majority of the responses were from oculoplastic consultants (64%, 44/69), with other responses from oculoplastic fellows (12%, 8/69), ophthalmology consultants (10%, 7/69), speciality training surgeons (6%, 4/69) and other ophthalmology clinicians (9%). The responses highlighted that there is a widespread level of subjective understanding of the topic of AI, a low level of current AI in clinical practice and an anticipation that AI will have a noticeable impact in the next one to five years (45%, 29/64) or five to 10 years (36%, 23/64) in the UK. Specific applications of applications of AI are also discussed in further detail. Conclusions Oculoplastic surgeons feel that AI will have an imminent role in this speciality, but there is a low level of self-rated knowledge and low current use of AI in clinical practice. Given the potential of this technology, further resources need to be invested into equipping Oculoplastic surgeons to feel more prepared for this technological revolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.